Skip to main content
OpenTrials
Completed

NCT Number: NCT00957333

Effects of Ketamine on Human Bladders and Its Possible Mechanisms

This study is aimed to evaluate the relationship between ketamine abused and bladder dysfunction and its possible mechanisms.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Taipei Medical University-Wan Fang Hospital

Taipei, Taiwan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult male or female
  • Cystitis (the clinicians ruled out the causes of bacterial infection)
  • Frequent micturition
  • The clinicians are willing to sign the ICF

Exclusion criteria

  • Suffers from the urinary system disease, is not suitable to carry on the urinary bladder biopsy sampling
  • Suffers from other diseases, doctor recognized that is not suitable to carry on the sampling
  • The clinicians are not willing to sign the ICF

Treatment and study plan

Ketamine

Other

Primary outcomes

  1. Substance Abuse Situation Record

    Time frame: 1 day

    Substance abuse situation record: ketamine

Secondary outcomes

  1. Urinary Bladder Capacity

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Taipei Medical University WanFang Hospital

Other

Registry information

Important dates

Study start
2009
Primary completion
2009
Study completion
2011
First posted
Aug 12, 2009
Registry last updated
Jan 14, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.